Quantcast
Last updated on April 18, 2014 at 12:57 EDT

Latest Cystic fibrosis Stories

2013-01-23 23:01:57

As flu season reaches epidemic proportions, use of the Spiro PD Personal Spirometer to monitor lung health may educate and motivate people with COPD, asthma, and other chronic respiratory conditions to get a flu vaccination. For more information, visit http://www.SpiroPD.com. Allentown, Pennsylvania (PRWEB) January 23, 2013 The flu epidemic now affects people in all 50 states and the District of Columbia. The young, the elderly, and those who already have lung conditions are hit hardest....

2013-01-21 20:20:48

LAS VEGAS, Jan. 21, 2013 /PRNewswire/ -- The Cystic Fibrosis Foundation is one step closer to finding a cure for cystic fibrosis thanks to a little help from some superstar friends. More than $1 million was raised in support of cystic fibrosis research efforts last night during a special performance "Adding Tomorrows with Celine Dion," a partnership with international music icon Celine Dion, Caesars Entertainment, AEG Live and the Cystic Fibrosis Foundation. Held at Caesars Palace, the...

2013-01-10 16:23:26

SOUTH SAN FRANCISCO, Calif., Jan. 10, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. today announced that dosing has begun in a randomized, double-blind, placebo-controlled Phase 2 clinical trial of KB001-A, the company's anti-PcrV Humaneered®, PEGylated monoclonal antibody fragment. The study will investigate the safety and efficacy of intravenously administered KB001-A as a treatment for chronic Pseudomonas aeruginosa (Pa) infection in cystic fibrosis patients. The Phase 2 study...

2012-12-20 20:21:58

LAS VEGAS, Dec. 20, 2012 /PRNewswire/ -- Celine Dion, Caesars Entertainment and AEG Live are teaming up to create a special one-night only event, "Adding Tomorrows with Celine Dion," to benefit the Cystic Fibrosis Foundation on Sunday, Jan. 20, 2013. Celine is one of the most widely respected and successful performers in pop music history, having sold more than 200 million albums worldwide. She is a five-time Grammy Award winner, including Album of the Year and Best Pop Album. Her...

2012-12-19 05:00:45

PMD Healthcare announces that the Spiro PD Personal Spirometer is a favorite Christmas, Hanukkah, Eid, and Kwanzaa gift for people with chronic respiratory conditions to monitor their lung function. For more information, visit http://www.SpiroPD.com Allentown, Pennsylvania (PRWEB) December 18, 2012 Family and friends of people with chronic breathing problems, such as asthma, COPD, bronchitis, emphysema, cystic fibrosis, and a lung transplant, are choosing the Spiro PD Personal Spirometer as...

2012-12-12 05:02:50

As CDC announces significant increases in flu activity in the US, indicating that an early flu season is underway, more people with chronic respiratory conditions are using Spiro PD Personal Spirometer to monitor their lung health. For more information, visit http://www.SpiroPD.com. Allentown, PA (PRWEB) December 11, 2012 The CDC has recently warned that the flu season is off to the earliest start in a decade, and that it could be severe. In order to protect their lung health, more people...

2012-12-06 08:27:06

SOUTH PLAINFIELD, N.J., Dec. 6, 2012 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced that the European Medicines Agency (EMA) has validated a Marketing Authorization Application (MAA) seeking conditional approval for ataluren, an investigational new drug for the treatment of patients with nonsense mutation Duchenne muscular dystrophy (nmDMD). Validation of the MAA confirms that the submission is complete and begins the EMA's Committee for Human Medicinal Products' (CHMP) review...

2012-12-03 12:27:20

Calling for the manufacturer and drug insurance plans to ensure CF patients receive equitable and affordable access to KALYDECO(TM) TORONTO, Dec. 3, 2012 /CNW/ - Health Canada has issued a Notice of Compliance (NOC) for KALYDECO(TM), approving the drug for use in Canada. This gives Canadian cystic fibrosis (CF) patients with the G551D mutation (ages six and older) a chance to gain access to this new, breakthrough treatment. Cystic Fibrosis Canada calls on Vertex Pharmaceuticals Inc....

Drugs That Limit Excess Mucus Could Save Lives
2012-11-26 19:53:34

Washington University School of Medicine Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions — excess mucus production. "There is good evidence that what kills people with severe COPD or asthma is mucus obstructing the airway," says Michael J. Holtzman, MD, the Selma and Herman Seldin Professor of...

2012-11-19 12:26:35

BETHESDA, Md., Nov. 19, 2012 /PRNewswire-USNewswire/ -- Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, today announced a major expansion of its research collaboration with Pfizer Inc. designed to discover new drugs to treat people with the most common mutation of CF, Delta F508. Under the new six-year pre-clinical research program with Pfizer, CFFT will invest up to $58 million to speed the...


Latest Cystic fibrosis Reference Libraries

Cystic Fibrosis
2013-07-19 15:03:45

Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...

More Articles (1 articles) »